Daxor
DXR
6 hedge funds and large institutions have $740K invested in Daxor in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
11% more capital invested
Capital invested by funds: $669K → $740K (+$71K)
0.05% more ownership
Funds ownership: 1.59% → 1.64% (+0.05%)
14% less funds holding
Funds holding: 7 → 6 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$28.1K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$14.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$1.88K |
| 2 |
Morgan Stanley
New York
|
-$1.56K |
DXR Hedge Fund Activity: Q2 2024 in Review
6 of the 6,930 institutional investors tracked by Wall St. Rank reported a position in Daxor (DXR) for Q2 2024, worth a combined $740K — up 11% from $669K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of DXR and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 2 added.
The largest buyer was UBS Group, adding an estimated $28.1K. The largest seller was Renaissance Technologies, cutting an estimated $1.88K.
- 6 institutional investors held Daxor (DXR) as of Q2 2024, down from 7 in Q1 2024.
- Funds reported $740K of Daxor stock for Q2 2024, up 11% quarter-over-quarter.
- 0 funds opened new Daxor positions in Q2 2024 and 1 closed out, a net change of -1 holder.
- The largest Daxor buyer in Q2 2024 was UBS Group, an estimated $28.1K added.
- The largest Daxor seller in Q2 2024 was Renaissance Technologies, an estimated $1.88K sold.
Based on aggregated 13F filings for Q2 2024.